Board Member in the News: Rudolph Tanzi in Neuron on the Role of Gene Crosstalk in Alzheimer’s Disease
On July 10, 2019, Neuron published research by AFAR expert Rudolph E. Tanzi, PhD, that explores how “crosstalk” between the genes TREM2 and CD33 might play a role in neuroinflammation and the origin of Alzheimer's disease.
Dr. Tanzi is an AFAR board member. He is the Director of the Genetics and Aging Research Unit at Massachusetts General Institute for Neurodegenerative Disease, and a Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School.
The study, “TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease,” will appear in print on September 4, 2019. Read the online edition here.
Dr. Tanzi's recent research on Gene Switching has been picked up by several additional outlets. Read about the research in Psychology Today.